11 March 2022 : Clinical Research
Comparison of Pain in Male Drug Rehabilitees with and without Human Immunodeficiency Virus in Yunnan Province, China
Simin Shen12AE, Zhangxiang Huang1F, Xiaolina Zhang1C, Xuejun Li3B, Kaiyang Zhao1BD, Kunhua Wang24AG, Xiaomei Zhang1AG*DOI: 10.12659/MSM.934996
Med Sci Monit 2022; 28:e934996
Table 4 PainDETECT questionnaire (PD-Q) mean scores for the drug rehabilitees with and without HIV.
| Drug rehabilitees without HIV (n=44) | Drug rehabilitees with HIV (n=58) | P value | |
|---|---|---|---|
| 70.84±1.16 | 2.3±1.93 | 0.006 | |
| 6.00 (13.64) | 22.00 (37.93) | 0.0061 | |
| Burning pain | 2.40±0.30 | 3.04±0.18 | 0.0561 |
| Stabbing pain | 2.00±0.28 | 2.76±0.16 | 0.0126 |
| Tenderness | 1.37±0.17 | 2.32±0.14 | <0.0001 |
| Lightning pain | 1.40±0.18 | 2.76±0.18 | <0.0001 |
| Crymodynia | 1.60±0.25 | 2.43±0.16 | 0.0036 |
| Numbness | 1.87±0.27 | 2.59±0.16 | 0.0193 |
| Pressure allergies | 1.87±0.25 | 2.11±0.10 | 0.3003 |
| <0.0001 | |||
| Nociceptive (PD-Q score ≤12) | 34 (77.27) | 28 (28.57) | |
| Mixed (PD-Q score 13–18) | 7 (15.90) | 25 (43.10) | |
| Neuropathic (PD-Q score ≥19) | 3 (6.81) | 5 (8.62) | |
| * values for the continuous variable comparisons were determined using the Wilcoxon rank sum test. values for the neuropathic pain category (likely/not likely) comparisons were determined using Pearson’s χ test or Fisher’s exact test if ≥25% of the expected counts were | |||